{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:43:01Z","timestamp":1793187781423,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":426,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008280","name":"University of Angers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.micinf.2022.105039","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T12:16:44Z","timestamp":1661343404000},"page":"105039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["COVID-19 and Fungal infections: a double debacle"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3555-4559","authenticated-orcid":false,"given":"Sara","family":"Mina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Yaakoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Annweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dub\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-7321","authenticated-orcid":false,"given":"Nicolas","family":"Papon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.micinf.2022.105039_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.semdp.2019.04.006","article-title":"Emerging respiratory infections: the infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella","volume":"36","author":"Bradley","year":"2019","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.micinf.2022.105039_bib2","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary bacterial infections associated with influenza pandemics","volume":"8","author":"Morris","year":"2017","journal-title":"Front Microbiol"},{"issue":"10","key":"10.1016\/j.micinf.2022.105039_bib3","article-title":"Viral bacterial co-infection of the respiratory tract during early childhood","volume":"362","author":"Brealey","year":"2015","journal-title":"FEMS Microbiology Letters [Internet]"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s12879-018-3548-0","article-title":"The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09","volume":"18","author":"MacIntyre","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.micinf.2022.105039_bib5","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib6","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","article-title":"Pathology and pathogenesis of severe acute respiratory syndrome","volume":"170","author":"Gu","year":"2007","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/2049-632X.12166","article-title":"The emergence of the Middle East Respiratory Syndrome coronavirus","volume":"71","author":"Milne-Price","year":"2014","journal-title":"Pathogens Disease"},{"issue":"102","key":"10.1016\/j.micinf.2022.105039_bib8","first-page":"33","article-title":"Why is coinfection with influenza virus and bacteria so difficult to control?","volume":"19","author":"Cauley","year":"2015","journal-title":"Discov Med"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib9","article-title":"Invasive fungal diseases during COVID-19: we should be prepared","volume":"30","author":"Gangneux","year":"2020","journal-title":"J\u00a0Mycolog Med"},{"issue":"5","key":"10.1016\/j.micinf.2022.105039_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251170","article-title":"Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. Huber VC","volume":"16","author":"Musuuza","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s11046-018-0306-1","article-title":"Eighty years of mycopathologia: a retrospective analysis of progress made in understanding human and animal fungal pathogens","volume":"183","author":"Chaturvedi","year":"2018","journal-title":"Mycopathologia"},{"key":"10.1016\/j.micinf.2022.105039_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhin.2021.04.001","article-title":"Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients","volume":"113","author":"Silva","year":"2021","journal-title":"J\u00a0Hosp Infect"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrmicro3231","article-title":"The co-pathogenesis of influenza viruses with bacteria in the lung","volume":"12","author":"McCullers","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10.1016\/j.micinf.2022.105039_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab510","article-title":"Coronavirus disease 2019\u2013associated invasive fungal infection","volume":"8","author":"Baddley","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/cid\/ciab223","article-title":"Coronavirus disease 2019\u2013associated pulmonary aspergillosis in mechanically ventilated patients","volume":"74","author":"Permpalung","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/vaccines8040713","article-title":"Covid-19-Associated pulmonary aspergillosis: the other side of the coin","volume":"8","author":"Costantini","year":"2020","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.4124","article-title":"Danger-associated molecular patterns (DAMPs) in acute lung injury: DAMPs in ALI","volume":"229","author":"Tolle","year":"2013","journal-title":"J\u00a0Pathol"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2022.105039_bib20","article-title":"The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry","author":"Peacock","year":"2022","journal-title":"Microbiology"},{"key":"10.1016\/j.micinf.2022.105039_bib21","series-title":"SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation","first-page":"1","article-title":"COVID-19 and toll-like receptor 4 (TLR4)","volume":"vol. 2021","author":"Aboudounya","year":"2021"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib23","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1038\/s41467-021-24521-x","article-title":"SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance","volume":"12","author":"Robinot","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib24","doi-asserted-by":"crossref","first-page":"e00094","DOI":"10.1128\/CMR.00094-21","article-title":"Pathogenesis of respiratory viral and fungal coinfections","volume":"35","author":"Salazar","year":"2022","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.tim.2022.01.002","article-title":"The battle for oxygen during bacterial and fungal infections","volume":"30","author":"Andr\u00e9","year":"2022","journal-title":"Trends Microbiol"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08830185.2021.1884248","article-title":"Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality","volume":"41","author":"Que","year":"2022","journal-title":"Int Rev Immunol"},{"issue":"15","key":"10.1016\/j.micinf.2022.105039_bib27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jmii.2020.08.016","article-title":"SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients","volume":"54","author":"Parrill","year":"2021","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib29","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2022.105039_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155323","article-title":"Cytokine profile and disease severity in patients with COVID-19","volume":"137","author":"Ghazavi","year":"2021","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/jof6020091","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment","volume":"6","author":"Arastehfar","year":"2020","journal-title":"JoF"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.4124","article-title":"Danger-associated molecular patterns (DAMPs) in acute lung injury: DAMPs in ALI","volume":"229","author":"Tolle","year":"2013","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.micinf.2022.105039_bib33","first-page":"3","article-title":"DAMP signaling in fungal infections and diseases","author":"Cunha","year":"2012","journal-title":"Front Immun [Internet]"},{"key":"10.1016\/j.micinf.2022.105039_bib34","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3389\/fphar.2020.01333","article-title":"Immunosuppressive drugs and COVID-19: a review","volume":"11","author":"Schoot","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.micinf.2022.105039_bib35","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19\u2014immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM Consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib36","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"The Lancet Rheumatology"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe4724","article-title":"JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality","volume":"7","author":"Stebbing","year":"2021","journal-title":"Sci Adv"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/ajrccm.165.7.2106014","volume":"165","author":"Gu","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1164\/rccm.200302-256OC","article-title":"Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury","volume":"168","author":"Rocco","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib40","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.3390\/ijms22073773","article-title":"Corticosteroids for COVID-19 therapy: potential implications on tuberculosis","volume":"22","author":"Gopalaswamy","year":"2021","journal-title":"IJMS"},{"issue":"9398","key":"10.1016\/j.micinf.2022.105039_bib41","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/jof6040286","article-title":"Is the frequency of candidemia increasing in COVID-19 patients receiving corticosteroids?","volume":"6","author":"Riche","year":"2020","journal-title":"JoF"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib43","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/myc.13258","article-title":"Epidemiology and Mycology of Candidaemia in non-oncological medical intensive care unit patients in a tertiary center in the United States: overall analysis and comparison between non-COVID-19 and COVID-19 cases","volume":"64","author":"Macauley","year":"2021","journal-title":"Mycoses"},{"issue":"9","key":"10.1016\/j.micinf.2022.105039_bib44","doi-asserted-by":"crossref","first-page":"e2838","DOI":"10.1093\/cid\/ciaa1594","article-title":"Candidemia in coronavirus disease 2019 (COVID-19) patients: incidence and characteristics in a prospective cohort compared with historical non\u2013COVID-19 controls","volume":"73","author":"Mastrangelo","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"13","key":"10.1016\/j.micinf.2022.105039_bib46","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.micinf.2022.105039_bib47","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105039_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijid.2020.07.061","article-title":"Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient","volume":"99","author":"Bhat","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib49","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7861\/clinmed.2020-0565","article-title":"Pneumocystis pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19","volume":"20","author":"Kelly","year":"2020","journal-title":"Clin Med"},{"issue":"8","key":"10.1016\/j.micinf.2022.105039_bib50","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/cid\/ciaa906","article-title":"Pneumocystis jirovecii pneumonia and severe acute respiratory syndrome coronavirus 2 coinfection in a patient with newly diagnosed HIV-1 infection","volume":"72","author":"Mang","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib51","article-title":"The diagnostic challenge of pneumocystis pneumonia and COVID -19 co-infection in HIV","volume":"9","author":"Broadhurst","year":"2021","journal-title":"Respirology Case Reports [Internet]"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib52","first-page":"84","article-title":"The presence of Pneumocystis jirovecii in critically ill patients with COVID-19","volume":"82","author":"Alanio","year":"2021","journal-title":"J\u00a0Infect"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib53","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib54","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study Group education and research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib55","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmi.2022.01.027","article-title":"Defining COVID-19 associated pulmonary aspergillosis: systematic review and meta-analysis","volume":"28","author":"Kariyawasam","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.micinf.2022.105039_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198005","article-title":"Co-infection with respiratory pathogens among COVID-2019 cases","volume":"285","author":"Zhu","year":"2020","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13613-020-00686-4","article-title":"COVID-19-associated invasive pulmonary aspergillosis","volume":"10","author":"Rutsaert","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib58","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19\u2013associated pulmonary aspergillosis","volume":"202","author":"van Arkel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.micinf.2022.105039_bib60","doi-asserted-by":"crossref","DOI":"10.4322\/acr.2021.313","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA) in a pregnant woman","volume":"11","author":"Agrawal","year":"2021","journal-title":"Autops Case Rep"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib61","doi-asserted-by":"crossref","first-page":"e01138","DOI":"10.1128\/Spectrum.01138-21","article-title":"COVID-19-Associated pulmonary aspergillosis, fungemia, and pneumocystosis in the intensive care unit: a retrospective multicenter observational cohort during the first French pandemic wave. Cuomo CA","volume":"9","author":"Bretagne","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib62","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/ccr3.4051","article-title":"Fatal invasive pulmonary aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus terreus : a case study","volume":"9","author":"Abolghasemi","year":"2021","journal-title":"Clin Case Rep"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib63","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2704.204895","article-title":"COVID-19\u2013Associated pulmonary aspergillosis, march\u2013august 2020","volume":"27","author":"Salmanton-Garc\u00eda","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.micinf.2022.105039_bib64","doi-asserted-by":"crossref","first-page":"e01229","DOI":"10.1128\/JCM.01229-21","article-title":"Aspergillus test profiles and mortality in critically ill COVID-19 patients. Hanson KE, editor","volume":"59","author":"Erg\u00fcn","year":"2021","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib65","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3201\/eid2607.201603","article-title":"Fatal invasive aspergillosis and coronavirus disease in an immunocompetent patient","volume":"26","author":"Blaize","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib66","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11046-020-00493-2","article-title":"Fatal invasive pulmonary aspergillosis in COVID-19 patient with acute myeloid leukemia in Iran","volume":"185","author":"Nasri","year":"2020","journal-title":"Mycopathologia"},{"issue":"3","key":"10.1016\/j.micinf.2022.105039_bib67","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/jof7030230","article-title":"Proven fatal invasive aspergillosis in a patient with COVID-19 and Staphylococcus aureus pneumonia","volume":"7","author":"van Someren Gr\u00e9ve","year":"2021","journal-title":"JoF"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib68","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jiac.2021.03.024","article-title":"A\u00a0fatal case of COVID-19-associated invasive pulmonary aspergillosis","volume":"27","author":"Iwanaga","year":"2021","journal-title":"J\u00a0Infect Chemother"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib69","article-title":"Two cases of COVID-19-associated pulmonary aspergillosis (CAPA)","volume":"10","author":"Lim","year":"2022","journal-title":"Respirology Case Reports [Internet]"},{"key":"10.1016\/j.micinf.2022.105039_bib70","article-title":"A\u00a0fatal case report of invasive pulmonary aspergillosis and mucormycosis coinfection in an immunocompetent patient with coronavirus disease 2019 in Korea","author":"Kim","year":"2022","journal-title":"Acute Crit Care"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib71","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients\u2014a multinational observational study by the European Confederation of Medical Mycology","volume":"28","author":"Prattes","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.micinf.2022.105039_bib72","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.micinf.2022.105039_bib73","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/jof6020091","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment","volume":"6","author":"Arastehfar","year":"2020","journal-title":"JoF"},{"issue":"11","key":"10.1016\/j.micinf.2022.105039_bib75","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s10096-011-1229-7","article-title":"A\u00a0prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility","volume":"30","author":"Mortensen","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib76","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1164\/rccm.202005-1945LE","article-title":"Fungal infection during COVID-19: does Aspergillus mean secondary invasive aspergillosis?","volume":"202","author":"Fekkar","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.micinf.2022.105039_bib77","first-page":"1","article-title":"The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay","volume":"2015","author":"Zhang","year":"2015","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib78","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"suppl_1","key":"10.1016\/j.micinf.2022.105039_bib79","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/mmy\/myx091","article-title":"Diagnosis of aspergillosis by PCR: clinical considerations and technical tips","volume":"56","author":"Barnes","year":"2018","journal-title":"Med Mycol"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib80","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib81","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/antibiotics11060771","article-title":"Epidemiology of candidemia and fluconazole resistance in an ICU before and during the COVID-19 pandemic era","volume":"11","author":"Routsi","year":"2022","journal-title":"Antibiotics"},{"issue":"5","key":"10.1016\/j.micinf.2022.105039_bib82","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/cid\/ciab562","article-title":"The landscape of candidemia during the coronavirus disease 2019 (COVID-19) pandemic","volume":"74","author":"Seagle","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.micinf.2022.105039_bib83","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3201\/eid2611.203504","article-title":"Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, april\u2013july 2020","volume":"26","author":"Chowdhary","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.micinf.2022.105039_bib84","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/myc.13332","article-title":"Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patients","volume":"64","author":"Kayaaslan","year":"2021","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib85","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/jof6040211","article-title":"COVID-19-Associated candidiasis (CAC): an underestimated complication in the absence of immunological predispositions?","volume":"6","author":"Arastehfar","year":"2020","journal-title":"JoF"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102564","article-title":"Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?","volume":"19","author":"Antinori","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib88","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A\u00a0national strategy to diagnose coronavirus disease 2019\u2013associated invasive fungal disease in the intensive care unit","volume":"73","author":"White","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.micinf.2022.105039_bib89","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/myc.13137","article-title":"Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: species identification and antifungal susceptibility pattern","volume":"63","author":"Salehi","year":"2020","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib90","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1186\/s12879-020-05543-0","article-title":"Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib91","doi-asserted-by":"crossref","first-page":"56","DOI":"10.15585\/mmwr.mm7002e3","article-title":"Candida auris outbreak in a COVID-19 specialty care unit \u2014 Florida, july\u2013august 2020","volume":"70","author":"Prestel","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib92","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1017\/ice.2020.368","article-title":"Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge","volume":"42","author":"Nori","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.micinf.2022.105039_bib93","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00134-022-06651-y","article-title":"Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination","volume":"48","author":"Buil","year":"2022","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib94","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.13225","article-title":"Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic","volume":"64","author":"Nucci","year":"2021","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib95","first-page":"e45","article-title":"COVID-19 associated invasive candidiasis","volume":"82","author":"Al-Hatmi","year":"2021","journal-title":"J\u00a0Infect"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib96","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/jof7060440","article-title":"Impact of the SARS-CoV-2 pandemic in candidaemia, invasive aspergillosis and antifungal consumption in a tertiary hospital","volume":"7","author":"Mulet Bayona","year":"2021","journal-title":"JoF"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib97","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12281-019-00349-3","article-title":"Pneumocystis jirovecii pneumonia: epidemiology, clinical manifestation and diagnosis","volume":"13","author":"White","year":"2019","journal-title":"Curr Fungal Infect Rep"},{"issue":"5","key":"10.1016\/j.micinf.2022.105039_bib98","article-title":"Diagnosing invasive candidiasis. Kraft CS","volume":"56","author":"Clancy","year":"2018","journal-title":"J\u00a0Clin Microbiol [Internet]"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib99","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/jof5040090","article-title":"Identification of mycoses in developing countries","volume":"5","author":"Arastehfar","year":"2019","journal-title":"JoF"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0040-1701215","volume":"41","author":"Gonzalez-Lara","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib101","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12879-019-4419-z","article-title":"Pooled analysis of T2 Candida for rapid diagnosis of candidiasis","volume":"19","author":"Tang","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib102","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/jof8070678","article-title":"Occurrence of candidemia in patients with COVID-19 admitted to five ICUs in France","volume":"8","author":"Blaize","year":"2022","journal-title":"JoF"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib103","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A\u00a0national strategy to diagnose coronavirus disease 2019\u2013associated invasive fungal disease in the intensive care unit","volume":"73","author":"White","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.micinf.2022.105039_bib104","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/jof7030178","article-title":"T2Candida for the diagnosis and management of invasive Candida infections","volume":"7","author":"Monday","year":"2021","journal-title":"JoF"},{"issue":"suppl_1","key":"10.1016\/j.micinf.2022.105039_bib105","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/jac\/dkx445","article-title":"What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead","volume":"73","author":"Bassetti","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib106","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash","year":"2019","journal-title":"JoF"},{"issue":"3","key":"10.1016\/j.micinf.2022.105039_bib107","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash","year":"2021","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.micinf.2022.105039_bib108","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/jof8030307","article-title":"Prevalence of COVID-19 associated mucormycosis in a German tertiary care hospital","volume":"8","author":"Scharmann","year":"2022","journal-title":"JoF"},{"issue":"9","key":"10.1016\/j.micinf.2022.105039_bib109","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease\u2013associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib110","doi-asserted-by":"crossref","first-page":"ofab566","DOI":"10.1093\/ofid\/ofab566","article-title":"Coronavirus disease 2019-associated mucormycosis in France: a rare but deadly complication","volume":"9","author":"Danion","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.micinf.2022.105039_bib111","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.micinf.2022.105039_bib112","doi-asserted-by":"crossref","first-page":"264.e5","DOI":"10.1016\/j.ajem.2020.09.032","article-title":"Mucormycosis with orbital compartment syndrome in a patient with COVID-19","volume":"42","author":"Werthman-Ehrenreich","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib113","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/alr.22785","article-title":"Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19)","volume":"11","author":"Karimi-Galougahi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib114","article-title":"A\u00a0case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19","volume":"13","author":"Waizel-Haiat","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.micinf.2022.105039_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01293","article-title":"Rhino-orbital Mucormycosis as a complication of severe COVID-19 pneumonia","volume":"26","author":"Alamin","year":"2021","journal-title":"IDCases"},{"issue":"10","key":"10.1016\/j.micinf.2022.105039_bib116","article-title":"Mucormycosis infection in severe COVID-19 patient with multiple underlying health conditions","volume":"9","author":"Heydarifard","year":"2021","journal-title":"Clin Case Rep [Internet]"},{"issue":"8","key":"10.1016\/j.micinf.2022.105039_bib117","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/vaccines9080826","article-title":"COVID-19 associated rhino-orbital mucormycosis complicated by gangrenous and bone necrosis\u2014a case report from Honduras","volume":"9","author":"Palou","year":"2021","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib118","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-245343","article-title":"Mucormycosis in a patient with COVID-19 with uncontrolled diabetes","volume":"14","author":"Shakir","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib119","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/IOP.0000000000001889","article-title":"Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome","volume":"37","author":"Mekonnen","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib120","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4103\/ijo.IJO_1053_21","article-title":"Orbital infarction syndrome secondary to rhino-orbital mucormycosis in a case of COVID-19: clinico-radiological features","volume":"69","author":"Rao","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.micinf.2022.105039_bib121","first-page":"85","article-title":"Rhinocerebral mucormycosis and COVID-19 pneumonia","volume":"12","author":"Alekseyev","year":"2021","journal-title":"J\u00a0Med Cases"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib122","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s13365-021-00996-8","article-title":"Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature","volume":"27","author":"Ostovan","year":"2021","journal-title":"J\u00a0Neurovirol"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib123","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?","volume":"14","author":"Revannavar","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.micinf.2022.105039_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2021.105957","article-title":"Sino-orbital mucormycosis in a COVID-19 patient: a case report","volume":"82","author":"Maini","year":"2021","journal-title":"International Journal of Surgery Case Reports"},{"key":"10.1016\/j.micinf.2022.105039_bib125","article-title":"Title of the article: paranasal mucormycosis in COVID-19 patient","author":"Saldanha","year":"2021","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.micinf.2022.105039_bib126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.22551\/2020.28.0703.10172","article-title":"A\u00a0case report of COVID-19 associated pulmonary mucormycosis","volume":"7","author":"Khan","year":"2020","journal-title":"Arch Clin Cases"},{"key":"10.1016\/j.micinf.2022.105039_bib127","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mmcr.2021.03.006","article-title":"Pulmonary aspergillosis and mucormycosis in a patient with COVID-19","volume":"32","author":"Johnson","year":"2021","journal-title":"Medical Mycology Case Reports"},{"issue":"3","key":"10.1016\/j.micinf.2022.105039_bib128","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/jof7030174","article-title":"A\u00a0fatal case of Rhizopus azygosporus pneumonia following COVID-19","volume":"7","author":"Kanwar","year":"2021","journal-title":"JoF"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature","volume":"186","author":"Garg","year":"2021","journal-title":"Mycopathologia"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/jof7020088","article-title":"Autopsy proven pulmonary mucormycosis due to Rhizopus microsporus in a critically ill COVID-19 patient with underlying hematological malignancy","volume":"7","author":"Zurl","year":"2021","journal-title":"JoF"},{"issue":"5","key":"10.1016\/j.micinf.2022.105039_bib131","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s15010-020-01561-x","article-title":"A\u00a0challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis","volume":"49","author":"Pasero","year":"2021","journal-title":"Infection"},{"issue":"11","key":"10.1016\/j.micinf.2022.105039_bib132","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.radcr.2020.09.026","article-title":"Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia","volume":"15","author":"Placik","year":"2020","journal-title":"Radiology Case Reports"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib133","article-title":"Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient \u2013 case report and review of literature","volume":"31","author":"Khatri","year":"2021","journal-title":"J\u00a0Med Mycol"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib134","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.oooo.2021.03.010","article-title":"Painful palatal lesion in a patient with COVID-19. Oral surgery, oral medicine","volume":"131","author":"Pauli","year":"2021","journal-title":"Oral Pathology and Oral Radiology"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib135","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5946\/ce.2020.180","article-title":"Rare and fatal gastrointestinal mucormycosis (zygomycosis) in a COVID-19 patient: a case report","volume":"53","author":"Monte Junior","year":"2020","journal-title":"Clin Endosc"},{"issue":"11","key":"10.1016\/j.micinf.2022.105039_bib136","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.5005\/jp-journals-10071-24026","article-title":"Cutaneous mucormycosis in a patient of severe COVID-19 pneumonia: a rarer than rare case report","volume":"25","author":"Joshi","year":"2021","journal-title":"Indian J Crit Care Med"},{"issue":"6","key":"10.1016\/j.micinf.2022.105039_bib137","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S2666-5247(20)30115-4","article-title":"Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study","volume":"1","author":"Hanley","year":"2020","journal-title":"The Lancet Microbe"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib138","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib139","article-title":"Mucormycosis associated with COVID-19 in two kidney transplant patients","volume":"23","author":"Arana","year":"2021","journal-title":"Transpl Infect Dis [Internet]"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib140","first-page":"633","article-title":"Mixed mold infection with Aspergillus fumigatus and Rhizopus microsporus in a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) patient","volume":"51","author":"Bellanger","year":"2021","journal-title":"Infectious Diseases Now"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib141","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib142","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"The Lancet Microbe"},{"issue":"1","key":"10.1016\/j.micinf.2022.105039_bib143","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.micinf.2022.105039_bib144","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J\u00a0Laryngol Otol"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.06.006","article-title":"Absence of Case of Mucormycosis (March 2020\u2013May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit","volume":"15","author":"Mulakavalupil","year":"2021","journal-title":"Diabetes Metabol Syndr: Clin Res Rev"},{"issue":"5","key":"10.1016\/j.micinf.2022.105039_bib146","first-page":"765","article-title":"Outbreaks of Mucorales and the species involved","volume":"185","author":"Walther","year":"2020","journal-title":"Mycopathologia"},{"issue":"4","key":"10.1016\/j.micinf.2022.105039_bib147","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal Co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"issue":"2","key":"10.1016\/j.micinf.2022.105039_bib148","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/JCM.01070-11","article-title":"Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization\u2013time of flight analyzer-mediated mass spectrometry","volume":"50","author":"Schr\u00f6dl","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.micinf.2022.105039_bib149","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1128\/JCM.00700-14","article-title":"Accuracy of matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry for identification of clinical pathogenic fungi: a meta-analysis. Warnock DW, editor","volume":"52","author":"Ling","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"issue":"17","key":"10.1016\/j.micinf.2022.105039_bib150","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.3390\/ijms22179265","article-title":"Development of a method of measuring \u03b2-D-glucan and its use in preemptive therapy for invasive fungal infections","volume":"22","author":"Yoshida","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.micinf.2022.105039_bib151","first-page":"ciab1066","article-title":"Evaluation of serum Mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial","author":"Millon","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.micinf.2022.105039_bib152","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/jof8050457","article-title":"Recent developments in the diagnosis of mucormycosis","volume":"8","author":"Dannaoui","year":"2022","journal-title":"JoF"},{"issue":"12","key":"10.1016\/j.micinf.2022.105039_bib153","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical Mycology in cooperation with the mycoses study Group education and research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457922001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457922001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:40:37Z","timestamp":1761144037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457922001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":152,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1286457922001095"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2022.105039","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and Fungal infections: a double debacle","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2022.105039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105039"}}